Search results

Skip to results

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 1 to 15 of 34 results for ibs

  1. Irritable bowel syndrome in adults: diagnosis and management (CG61)

    This guideline covers diagnosing and managing irritable bowel syndrome (IBS) in people aged 18 and over. It details how to accurately diagnose IBS, and aims to improve the quality of life for adults with IBS by promoting effective management using dietary and lifestyle advice, pharmacological therapy and referral for psychological interventions.

    Clinical guideline
    Last updated
    4 April 2017
    View recommendations

    Sections for CG61

  2. Faecal calprotectin diagnostic tests for inflammatory diseases of the bowel (DG11)

    Evidence-based recommendations on faecal calprotectin tests for distinguishing between inflammatory bowel diseases (such as Crohn’s disease and ulcerative

    Diagnostics guidance
    Published
    2 October 2013
    View recommendations

    Sections for DG11

  3. Ovarian cancer: recognition and initial management (CG122)

    This guideline covers detecting, diagnosing and treating women (18 years and older) who have, or are suspected of having, epithelial ovarian cancer, fallopian tube cancer, primary peritoneal cancer or borderline ovarian cancer. It aims to enable earlier detection of ovarian cancer and improve initial treatment.

    Clinical guideline
    Last updated
    2 October 2023
    View recommendations

    Sections for CG122

  4. Improving evidence-based management of irritable bowel syndrome across Somerset

    (CG61) in 2008 aiming for appropriate management of irritable bowel syndrome (IBS) within primary care, its recommendations were not...

    Shared learning
    Last updated
    28 February 2018

  5. SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea (DG44)

    Evidence-based recommendations on SeHCAT (tauroselcholic [75 selenium] acid) for diagnosing bile acid diarrhoea

    Diagnostics guidance
    Published
    17 November 2021
    View recommendations

    Sections for DG44

  6. Refractory [Irritable bowel syndrome] (IBS):- What factors contribute to refractory IBS?

    CG61/3 Question Refractory [Irritable bowel syndrome] (IBS):- What factors contribute to refractory IBS? Any...

    Research recommendation
    Published
    9 June 2015

  7. Irritable bowel syndrome in adults (QS114)

    This quality standard covers diagnosing and managing irritable bowel syndrome in adults. It describes high-quality care in priority areas for improvement.

    Quality standard
    Published
    11 February 2016
    View quality statements

    Sections for QS114

  8. Implementing faecal calprotectin testing in primary care

    differential diagnosis of inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS) in adults with recent onset...

    Shared learning
    Last updated
    12 March 2016

  9. Relaxation and biofeedback:- What is the effect of relaxation and biofeedback therapies on [Irritable bowel syndrome] (IBS) symptoms and patient-related outcomes?

    What is the effect of relaxation and biofeedback therapies on [Irritable bowel syndrome] (IBS) symptoms and patient-related...

    Research recommendation
    Published
    9 June 2015

  10. Psychological interventions:- Are the psychological interventions [cognitive behavioural therapy] (CBT), hypnotherapy and psychological therapy all equally effective in the management of [Irritable bowel syndrome] (IBS) symptoms, either as first-line therapies in primary care, or in the treatment of people with IBS that is refractory to other treatments?

    management of [Irritable bowel syndrome] (IBS) symptoms, either as first-line therapies in primary care, or in the...

    Research recommendation
    Published
    9 June 2015

  11. Evaluation of guidelines for the use of faecal calprotectin testing in primary care

    to support a diagnosis of inflammatory bowel disease (IBD) or irritable bowel syndrome (IBS). The Department of...

    Shared learning
    Last updated
    26 August 2015

  12. Irritable bowel syndrome

    All NICE products on irritable bowel syndrome. Includes any guidance, advice and quality standards.

    Topic page

  13. Herbal medicines:- Are Chinese and non-Chinese herbal medicines safe and effective as first-line therapy in the treatment of [Irritable bowel syndrome] (IBS), and which is the most effective and safe option?

    safe and effective as first-line therapy in the treatment of [Irritable bowel syndrome] (IBS), and which is the most...

    Research recommendation
    Published
    9 June 2015

  14. Research is needed to establish the efficacy and tolerability of bile acid sequestrants among people with irritable bowel syndrome (IBS-D) or Crohn's disease without ileal resection.

    and tolerability of bile acid sequestrants among people with irritable bowel syndrome (IBS-D) or Crohn's disease without...

    Research recommendation
    Published
    9 June 2015

  15. Research is needed to establish the nature of bile acid malabsorption and whether bile acid malabsorption is a primary or secondary condition in people diagnosed with irritable bowel syndrome (IBS-D) or Crohn's disease without ileal resection.

    is a primary or secondary condition in people diagnosed with irritable bowel syndrome (IBS-D) or Crohn's disease without...

    Research recommendation
    Published
    9 June 2015